Clinical Trials - November 10, 2025
Lytix Biopharma announces new immune response data
The company has presented immune response data on ruxotemitide (formerly LTX-315/VP-315) at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in National Harbor, Maryland.
Pharma article - November 10, 2025
AstraZeneca part of new Swedish collaboration on green technology
The Swedish government is investing SEK 95 million in a public-private partnership to create an innovation platform that will reduce Sweden's climate emissions and strengthen competitiveness. Partners in the collaboration are the government, AstraZeneca, Scania and RISE.
Acquisition - November 7, 2025
The takeover offer of Bavarian Nordic is withdrawn and will not be completed
Earlier this autumn the company announced a takeover offer to acquire all of the issued and outstanding shares in Bavarian Nordic by Innosera, a company controlled by Nordic Capital Fund XI and funds managed and advised by Permira Beteiligungsberatung. The offeror has now informed Bavarian Nordic that, as the minimum acceptance condition has not been satisfied, […]
In a new job - November 6, 2025
She is the new CEO of QuNorth
Ebba Carbonnier has been appointed CEO of QuNorth, a Nordic quantum initiative established by the Novo Nordisk Foundation and EIFO (Export and Investment Fund of Denmark) with the purpose of acquiring and operating the world’s most powerful quantum computer.
MedTech Business - November 6, 2025
Mölnlycke establishes first wound care manufacturing site in China
The manufacturing site, spanning 10,000 m2 is expected to initiate production of Mölnlycke wound care products at the end of 2026/early 2027.
Biotech Business - November 6, 2025
AAX Biotech and ToxoTech to advance next-generation biotherapeutics for neurological disorders
The two companies have announced a strategic collaboration to advance next-generation biotherapeutics, they state.
